logo
NSEI:AJANTPHARM logo

Ajanta Pharma Community

NSEI:AJANTPHARM Community
  • 1 Narratives written by author
  • 0 Comments on narratives written by author
  • 7 Fair Values set on narratives written by author
Create a narrative

Community Investing Ideas

AJANTPHARM logo
Ajanta Pharma
AN
AnalystConsensusTarget
Consensus Narrative from 12 Analysts

New Product Launches And Liquid Plant Will Expand Presence

Key Takeaways Ajanta Pharma's expansion in Asia and Africa through new product launches and chronic therapies supports long-term revenue growth. Strategic pipeline and entry into new therapeutic areas enhance growth, while new manufacturing capabilities improve margins and cost control.
View narrative
₹3.09k
FV
19.5% undervalued intrinsic discount
12.31%
Revenue growth p.a.
0users have liked this narrative
0users have commented on this narrative
5users have followed this narrative
11 days ago author updated this narrative